Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Helicase Venture is an early-stage venture capital firm founded in Boston, Massachusetts. Established to support transformative companies in the healthcare sector, the firm focuses on life sciences and Bio-IT. Helicase Venture aims to empower early-stage companies by providing strategic guidance and access to a broad network of scientific advisors. The firm has a portfolio of approximately 10 companies, reflecting its commitment to investing in innovative technologies that can significantly improve health outcomes.
Currently, Helicase Venture operates with a team of experienced professionals, including Managing Partner Richard Tsai, PhD, and Partner Joy Lee, PhD. The firm primarily invests in North America, concentrating on seed and Series A funding rounds. Helicase Venture's approach combines financial investment with active involvement in the growth and development of its portfolio companies, ensuring they reach their full potential.
Helicase Venture targets early-stage investment opportunities, specifically in the seed and Series A stages. The firm typically commits between $1 million and $5 million in initial investments, focusing on life sciences and computational technologies. Their investment thesis emphasizes the importance of engineering health and artificial intelligence in addressing significant healthcare challenges. Helicase Venture seeks companies that demonstrate innovative approaches to improving health outcomes, particularly those leveraging advanced technologies.
The firm is particularly interested in startups that operate within the biotech, healthcare, and AI sectors. Helicase Venture looks for founders who possess a strong vision and the capability to execute their ideas effectively. The firm values collaboration and often engages with its portfolio companies to provide strategic guidance and access to a wide range of scientific networks and advisors.
Helicase Venture's portfolio includes a diverse range of companies that are making significant strides in the life sciences and Bio-IT sectors. Notable portfolio companies include:
Richard Tsai, PhD: Managing Partner at Helicase Venture, Richard has a strong background in life sciences and venture capital. He has led numerous investments in innovative healthcare companies and holds a PhD in a relevant scientific field.
Joy Lee, PhD: Partner at Helicase Venture, Joy brings expertise in biotechnology and healthcare investments. She has a proven track record of supporting early-stage companies and holds a PhD in a related discipline.
To pitch Helicase Venture, founders should send an email to newlp@helicaseventure.com. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, and technology. Helicase Venture values clarity and detail in presentations. Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In recent months, Helicase Venture has been actively investing in life sciences startups. Notably, the firm participated in the $80 million Series C financing for Contineum Therapeutics, formerly known as Pipeline Therapeutics. This investment highlights Helicase Venture's commitment to supporting innovative approaches in biotechnology and therapeutics.
Additionally, Helicase Venture has made investments in Medeon Biodesign and has been involved with an Austrian biotech company through co-investment with BRANDL TALOS. The firm continues to expand its portfolio, focusing on companies that leverage advanced technologies for healthcare solutions.
What are Helicase Venture's investment criteria?
Helicase Venture primarily invests in early-stage companies within the biotech, healthcare, and AI sectors. They focus on seed and Series A rounds, committing between $1 million and $5 million in initial investments. The firm looks for innovative technologies that can significantly improve health outcomes.
How can I apply or pitch to Helicase Venture?
Founders can pitch to Helicase Venture by sending an email to newlp@helicaseventure.com. It is advisable to include a detailed business plan and an overview of the technology or product being developed.
What makes Helicase Venture different from other investors?
Helicase Venture differentiates itself through its specialized focus on life sciences and Bio-IT. The firm provides not only capital but also strategic guidance and access to a broad network of scientific advisors, which can be crucial for early-stage companies.
What is Helicase Venture's geographic scope?
The firm primarily invests in North America, concentrating on startups that are based in this region. This geographic focus allows them to engage closely with their portfolio companies.
What is Helicase Venture's post-investment involvement like?
Helicase Venture is actively involved with its portfolio companies, providing strategic guidance and leveraging its network of scientific advisors to help startups reach their full potential. The firm emphasizes collaboration and support throughout the growth process.
What is the typical check size for investments?
Helicase Venture typically invests between $1 million and $5 million in its portfolio companies, focusing on early-stage funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.